Anthony van Dyck Collection in New York had an exhibition "Van Dyck: The Anatomy of Portraiture", the first major survey of the artist's work in the United States in over two decades. Anthony van Dyck Sir Anthony van Dyck (, many variant spellings; 22 March 1599 – 9 December 1641) was a Flemish Baroque artist who became the leading court painter in England after success in the Southern Netherlands and Italy. The seventh child of Frans van Dyck, a wealthy Antwerp silk merchant, Anthony was precocious as a youth and painted from an early age. In his late teens he was already enjoying
Christopher H. van Dyck brain. Studies of this ligand in early Alzheimer’s Disease patients have shown a loss of synapses from the perforant path, the connections between the entorhinal cortex and hippocampal formation needed for memory consolidation. van Dyck and the Yale ADRU have tested potential Alzheimer’s therapeutics for over 20 years. They have contributed to the successful development of memantine now in use for the treatment of mid-late stage Alzheimer’s Disease, and assess potential new therapeutic strategies, e.g. antibodies that reduce amyloid pathology such as Crenezumab, and based on the work of Dr. Stephen Strittmatter, an inhibitor of fyn. Dr. van Dyck serves